Drug therapy in the neonatal foal.

The research article studies the unique effects of drug treatments in neonatal foals, especially in their first week of life, and recommends appropriate dosages, careful administration, and close monitoring due to these foals’ physiological sensitivity and differences from older horses.

Understanding Neonatal Foal Pharmacokinetics

• The research primarily targets the study of pharmacokinetics—at how prepubescent animals absorb, distribute, and eliminate drugs—in neonatal foals (horse offspring within 7 days of being born).
• The study acknowledges that drug effects vary between neonatal foals and older horses, especially during the foals’ first three days of life. These differences are attributed to the maturational changes happening within the young horses, whose physiological processes adapt over time.
• The researchers insist on a unique dosage regimen for neonates that takes into account their distinct pharmacokinetic profile of drugs, further highlighting the need for constant monitoring of their response to treatments for early spotting of signs of toxicity.

Managing Neonatal Foal Diseases

• In managing neonatal foal diseases, the study stresses the significance of maintaining good nursing practices and providing supportive therapies.
• Specific environmental factors, such as overcrowding, could cause stress among foals, making them susceptible to bacterial and parasitic infections. Hence, it is essential to control these external factors.
• The study emphasizes the importance of microbiological diagnosis prior to the administration of antimicrobial therapy. The most common bacterial infection in neonatal foals is caused by E.coli, but other bacterial pathogens may also cause unpredictable infections. Thus, a thorough diagnosis is required.
• The selection of antimicrobial drugs should be based on both microbiological (quantitative susceptibility) and pharmacological (pharmacokinetic) properties of the drug, aiming for a bactericidal effect.

Choice of Drugs and Route of Administration

• The study identifies diazepam as the preferred sedative for neonatal foals. For gastric ulcers, cimetidine, an H2-receptor antagonist, may be used, though it reduces the metabolic breakdown of other concurrently administered drugs.
• Nonsteroidal anti-inflammatory drugs, such as flunixin and phenylbutazone, have a higher incidence of toxicity in neonatal foals, so their administration should be at lower dosages than for adult horses.
• The research also focuses on the importance of slow intravenous infusions to maintain hydration and electrolyte balance, asserting that neonatal foals have reduced renal functions, limiting their ability to excrete excessive fluids.
• Given these details, the researchers stress the need for precision in drug dosages, mindful administration routes and rates, and careful monitoring of pharmacologic effects when treating neonatal foals.